These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1525190)

  • 61. Efficacy of treatment for ulcerative colitis.
    Steinberg H
    JAMA; 1998 Aug; 280(5):422. PubMed ID: 9701075
    [No Abstract]   [Full Text] [Related]  

  • 62. Mesalamine-induced lung toxicity.
    Bitton A; Peppercorn MA; Hanrahan JP; Upton MP
    Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
    Bayerdörffer E; Bock H
    Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 5-ASA for ulcerative colitis.
    Meyers S; Janowitz HD
    N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160
    [No Abstract]   [Full Text] [Related]  

  • 65. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
    Eliakim R; Wengrower D; Ligumsky M; Rachmilewitz D
    Isr J Med Sci; 1990 Jan; 26(1):47-9. PubMed ID: 1968895
    [No Abstract]   [Full Text] [Related]  

  • 66. Disposition of 5-aminosalicylic acid by 5-aminosalicylic acid-delivering compounds.
    Rijk MC; van Schaik A; van Tongeren JH
    Scand J Gastroenterol Suppl; 1988; 148():54-9. PubMed ID: 2906478
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug induced otalgia due to mesalazine and sulphasalazine.
    Wareing M; Mitchell D
    J Laryngol Otol; 1996 May; 110(5):466-7. PubMed ID: 8762319
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid].
    Malchow H
    Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152
    [No Abstract]   [Full Text] [Related]  

  • 71. Sulfasalazine lung. Desensitization to sulfasalazine and treatment with acrylic coated 5-ASA and azodisalicylate.
    Sullivan SN
    J Clin Gastroenterol; 1987 Aug; 9(4):461-3. PubMed ID: 2888803
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
    Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
    Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.
    Staerk Laursen L; Stokholm M; Bukhave K; Rask-Madsen J; Lauritsen K
    Gut; 1990 Nov; 31(11):1271-6. PubMed ID: 2253912
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comment: mesalamine in ulcerative colitis.
    Rothbart D
    DICP; 1991 Sep; 25(9):1015-6. PubMed ID: 1683077
    [No Abstract]   [Full Text] [Related]  

  • 75. A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis.
    Campieri M; Lanfranchi GA; Bertoni F; Brignola C; Bazzocchi G; Minguzzi MR; Labò G
    Digestion; 1984; 29(4):204-8. PubMed ID: 6381184
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical tolerance of olsalazine.
    Järnerot G
    Scand J Gastroenterol Suppl; 1988; 148():21-3. PubMed ID: 3067337
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.
    Sutherland LR; Martin F; Greer S; Robinson M; Greenberger N; Saibil F; Martin T; Sparr J; Prokipchuk E; Borgen L
    Gastroenterology; 1987 Jun; 92(6):1894-8. PubMed ID: 3569765
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
    Bresci G; Carrai M; Venturini G; Gambardella L
    Minerva Dietol Gastroenterol; 1990; 36(1):31-3. PubMed ID: 1970855
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sulfasalazine and new analogues.
    Friedman G
    Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653
    [No Abstract]   [Full Text] [Related]  

  • 80. Which 5-ASA?
    Travis SP
    Gut; 2002 Oct; 51(4):548-9. PubMed ID: 12235078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.